2026 NPPES data Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician NPI 1538666334 MD
Verify on CMS →

SARAH ROZYCKI, MD

Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician in HOUSTON, Texas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
156
Medicare Part D claims · 110 beneficiaries · Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician avg: 611
Generic prescribing
86%
generic claims · 14% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$826.55
12 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

SARAH ROZYCKI, MD filed 156 Medicare Part D claims in 2023 as a Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician in HOUSTON, Texas, prescribing 86% generic.

156
Part D claims, 2023
86%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

SARAH ROZYCKI, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

156 35th percentile higher than 35% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). This entry sits in this band. 200–400: 182,923 prescribers (13%). Above this entry. 400–600: 90,619 prescribers (7%). Above this entry. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic — not verified)

SARAH ROZYCKI, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 2 hospital affiliations — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about SARAH ROZYCKI, MD?

Quality data not reported

NPI registry status

Active

Issued 04/09/2018

NPI 1538666334

Primary specialty

Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician

Niche

568 US NPIs in this specialty

Medicare Part D claims

156 74% vs specialty avg

2023 prescription claims

Specialty avg: 611

Specialty distribution in Texas

How Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician compares to other specialties among Texas providers

Texas providers

Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician share within Texas

1. Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician share within Texas

Specialty board-certification context

Estimated specialty board-certified rate — Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician ABMS/AOA estimate

Est. board-certified rate (Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

SARAH ROZYCKI, MD is a Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician provider practicing in HOUSTON, Texas, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1538666334. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

SARAH ROZYCKI, MD appears in the CMS NPPES registry as a Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician provider holding MD credentials at 6550 FANNIN ST STE 2221, HOUSTON, TX, 77030, with a listed phone of (713) 441-1577. NPI 1538666334 was issued on 04/09/2018. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what ROZYCKI most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 156 prescription claims written by this provider, covering 110 Medicare beneficiaries and totaling roughly $13K in drug spend, split 14% brand-name and 86% generic by claim count, with an opioid prescribing rate of 11.5%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician is a narrow specialty nationwide, with 568 enrolled providers across 49 states and an average of 611 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

6550 FANNIN ST STE 2221
HOUSTON, TX 77030

Provider Details

NPI 1538666334
Specialty Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician
Credentials MD
Gender Female
NPI Issued 04/09/2018

Hospital and facility affiliations

Facilities where SARAH ROZYCKI, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

HOUSTON METHODIST SPECIALTY PHYSICIANS
HOUSTON, TX
TMH PHYSICIAN ASSOCIATES PLLC
BELLAIRE, TX

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for SARAH ROZYCKI, MD. Source: openpaymentsdata.cms.gov.

Total received

$827

Largest payer

Boston Scientific Corporation

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Texas TMB 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 — they are NOT specific to SARAH ROZYCKI, MD. To verify SARAH ROZYCKI, MD's current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases

TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

SARAH ROZYCKI, MD — brand share 14.0%
Specialty average (est.)

14% brand-name claims vs 86% generic, on 156 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

156
Total Claims
$13K
Total Drug Cost
110
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
198
Total Day Supply
3,074
Brand vs Generic
14% brand / 86% generic
Brand Drug Cost
$10K
Generic Drug Cost
$3K
Opioid Claims
18 (11.5% rate)
Antibiotic Claims
71

Patient Demographics

Average Patient Age
74.1 years
Avg HCC Risk Score
1.23

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Nitrofurantoin Mono-Macro
Nitrofurantoin Monohyd/M-Cryst
30
Estradiol
19
Tramadol Hcl
16
Ibuprofen
15
Sulfamethoxazole-Trimethoprim
Sulfamethoxazole/Trimethoprim
13

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician Overview

How SARAH ROZYCKI, MD fits within the Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician landscape nationally.

568
Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician Providers in US
49
States with Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician
611
Avg Claims per Provider

SARAH ROZYCKI, MD's 156 claims are below the specialty average of 611.

Nearby Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician Providers in Texas

Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as ROZYCKI.

Compare Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is SARAH ROZYCKI, MD's specialty?
SARAH ROZYCKI, MD specializes in Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician and practices in HOUSTON, Texas. Credentials: MD.
How much does SARAH ROZYCKI, MD prescribe under Medicare Part D?
In 2023, SARAH ROZYCKI, MD wrote 156 Medicare Part D claims totaling $13K in drug costs for 110 beneficiaries.
Where is SARAH ROZYCKI, MD located?
SARAH ROZYCKI, MD is located at 6550 FANNIN ST STE 2221, HOUSTON, TX, 77030. Phone: (713) 441-1577.
What is SARAH ROZYCKI, MD's NPI number?
SARAH ROZYCKI, MD's National Provider Identifier (NPI) is 1538666334, issued on 04/09/2018.
Does SARAH ROZYCKI, MD prescribe more brand-name or generic drugs?
SARAH ROZYCKI, MD's prescribing is 14% brand-name and 86% generic drugs by claim count, with $10K in brand drug costs.
Does SARAH ROZYCKI, MD prescribe opioids?
Yes, SARAH ROZYCKI, MD had 18 opioid claims in 2023 with an opioid prescribing rate of 11.5%.
How many Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician providers are there in the US?
There are 568 Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician providers across 49 states in the US. The average Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician provider writes 611 Medicare Part D claims per year.
What drugs does SARAH ROZYCKI, MD prescribe most often?
Based on 2023 Medicare Part D data, SARAH ROZYCKI, MD's most frequently prescribed drugs include Nitrofurantoin Mono-Macro, Estradiol, Tramadol Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does SARAH ROZYCKI, MD accept Medicare?
SARAH ROZYCKI, MD appears in CMS Medicare data with 156 Part D claims and 110 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify SARAH ROZYCKI, MD's credentials?
SARAH ROZYCKI, MD's NPI is 1538666334 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology